DNA Script raises EUR11M in series A

On Sept. 12, synthetic DNA manufacturer DNA Script (Paris, France) said it raised €11 million ($13 million) in a series A round led by Illumina Ventures. Merck Ventures BV participated along with existing investors Sofinnova Partners, Kurma Partners and Idinvest Partners.

DNA Script spokesperson Justin Jackson told BioCentury the company will use the funding, which it expects to cover the next two years, to develop its lab-based enzymatic technology and nucleotide chemistry platform for industrial scale-up...